Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Need to raise more cash, chart shows 0.065 next.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(445)
•••
Comment by Liked2Thinkon May 09, 2022 11:50am
106 Views
Post# 34667165

RE:RE:RE:RE:RE:RE:Need to raise more cash, chart shows 0.065 next.

RE:RE:RE:RE:RE:RE:Need to raise more cash, chart shows 0.065 next.You do realize that the pumpers werent terminating your MULTIPLE ACCOUNTS that you just admitted to again.

The admins for this site viewed your idiotic posts and your multiple posts one after another as insane and they terminated your accounts after having been brought to their attention by all other members.

Yet you still continue creating new account after new accounts posting even dumber things than you did before.  

Whats even dumber is that you think anyone here believes you were doing this to "warn us".  A couple posts here and there maybe we could believe that but the constant acount creating, the triple posts in a row, and the never ending BS just proves you are nothing but a dirtbag shorter.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities